Attachment and Prognostic Factor: the Implicit Approach
NCT ID: NCT04954027
Last Updated: 2025-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
200 participants
OBSERVATIONAL
2026-09-30
2028-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
5 visits are planned during the study :
* the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online
* 4 telephone interviews for follow-up by investigator.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment Adherence in Substance Users
NCT02930577
A Prospective Clinical Study of a Cohort of Patients Seeking Treatment for a Behavioral Addiction
NCT01248767
Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool
NCT06618755
Interaction Patients Experts During the Addiction Care Pathways
NCT05284370
Portrayal of Hospital Alcohol Detoxification in France
NCT04973202
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with a use-related disorder weaning for a substance
Questionnaires
5 visits are planned during the study :
* the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online
* 4 telephone interviews for follow-up by investigator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires
5 visits are planned during the study :
* the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online
* 4 telephone interviews for follow-up by investigator
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a use-related disorder as defined by DSM5
* Patients weaning for a substance, supported within the addictology sector of Henri Laborit Hospital
* Having expressed non-opposition to participating in the study after receiving written information.
Exclusion Criteria
* Simultaneous participation in a therapeutic trial involving oxytocin
* Patients protected by law
* Patients who do not have French as their native language
* Patients who, in the opinion of the investigator, are unable to complete the questionnaires
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Henri Laborit
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wilfried SERRA, Dr
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Henri Laborit
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A00432-39
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.